Recursion Pharmaceuticals SG&A Expense (Quarterly) Analysis

Recursion Pharmaceuticals Inc (RXRX)

9.37 +0.11 (+1.19%) USD | NASDAQ | Jun 17, 16:00

9.39 +0.02 (+0.21%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	31.41M
December 31, 2023	30.46M
September 30, 2023	29.20M
June 30, 2023	28.29M
March 31, 2023	22.87M
December 31, 2022	19.84M
September 30, 2022	19.49M
June 30, 2022	21.20M
March 31, 2022	21.07M

Date	Value
December 31, 2021	19.20M
September 30, 2021	15.69M
June 30, 2021	13.85M
March 31, 2021	8.937M
December 31, 2020	7.574M
September 30, 2020	6.964M
June 30, 2020	5.159M
March 31, 2020	5.561M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

5.159M

Minimum

Jun 2020

31.41M

Maximum

Mar 2024

18.05M

Average

19.49M

Median

Sep 2022

SG&A Expense (Quarterly) Benchmarks